Suzanne Conzen, MD, is expediting the bench-to-bedside process with a rare investigator-initiated Phase I clinical trial for a novel approach to breast cancer therapy.
Read full story »
Three UChicago physicians (left to right) Adam Cifu, MD, Scott Stern, MD, and Diane Altkorn, MD, developed the content for a new Web app diagnosis tool licensed by startup Agile Diagnosis.
Read full story »
Professor Ralph Weichselbaum, MD, and colleagues are working to validate a new test to predict individual benefit from radiation or chemotherapy, an effort funded by UChicago.
Read full story »
The University awarded investigator Michael Thirman, MD, $50,000 to continue his research on a promising drug candidate for treating a devastating form of leukemia.
Read full story »
Licensees of Dmitri Talapin's "electronic glue" and nanocrystal technology are developing a number of killer apps
Read full story »
Cardiologist Michael Davidson, MD, has co-founded two companies and is currently developing a promising therapy that may help lower cholesterol levels.
Read full story »
Co-investigators Susan Cohn and Alexandre Chlenski received one of two pilot innovation fund grants to explore the broader use of a drug candidate they've developed for treating cancer.
Read full story »
UChicagoTech is a resource and partner for investigators who want to explore and develop the translational and commercial potential of their research. This section provides information to help you get started.
We invite you to Contact Us early and often:
Sign up to receive periodic updates of UChicagoTech news and events.